434 related articles for article (PubMed ID: 6184401)
1. Antigen-presenting capabilities of human monocytes correlates with their expression of HLA-DS, an Ia determinant distinct from HLA-DR.
Gonwa TA; Picker LJ; Raff HV; Goyert SM; Silver J; Stobo JD
J Immunol; 1983 Feb; 130(2):706-11. PubMed ID: 6184401
[TBL] [Abstract][Full Text] [Related]
2. Expression of HLA-DR, MB, MT and SB antigens on human mononuclear cells: identification of two phenotypically distinct monocyte populations.
Nuñez G; Giles RC; Ball EJ; Hurley CK; Capra JD; Stastny P
J Immunol; 1984 Sep; 133(3):1300-6. PubMed ID: 6611370
[TBL] [Abstract][Full Text] [Related]
3. Differential abilities of human peripheral blood monocytes quantitatively or qualitatively differing in HLA-DR and HLA-DS expression to support B cell activation in liquid and semisolid cultures.
Whisler RL; Newhouse YG; Lachman LB
J Immunol; 1985 Jul; 135(1):172-9. PubMed ID: 3873488
[TBL] [Abstract][Full Text] [Related]
4. Antigen presentation by interferon-gamma-treated endothelial cells and fibroblasts: differential ability to function as antigen-presenting cells despite comparable Ia expression.
Geppert TD; Lipsky PE
J Immunol; 1985 Dec; 135(6):3750-62. PubMed ID: 3934267
[TBL] [Abstract][Full Text] [Related]
5. Requirement of Ia-positive accessory cells in the MLR response against class II antigen on human B cell tumor line.
Yamamoto M; Yano A
J Immunol; 1985 Dec; 135(6):3887-96. PubMed ID: 2999233
[TBL] [Abstract][Full Text] [Related]
6. Two distinct class II molecules encoded by the genes within HLA-DR subregion of HLA-Dw2 and Dw12 can act as stimulating and restriction molecules.
Sone T; Tsukamoto K; Hirayama K; Nishimura Y; Takenouchi T; Aizawa M; Sasazuki T
J Immunol; 1985 Aug; 135(2):1288-98. PubMed ID: 3159789
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibodies to HLA-DP, DQ, and DR determinants: functional effects on the activation and proliferation of normal and EBV-transformed B cells.
Howard DR; Eaves AC; Takei F
Exp Hematol; 1986 Oct; 14(9):887-95. PubMed ID: 2428652
[TBL] [Abstract][Full Text] [Related]
8. Ia antigen on peripheral blood mononuclear leukocytes in man. I. Expression, biosynthesis, and function of HLA-DR antigen non-T cells.
Engleman EG; Charron DJ; Benike CJ; Stewart GJ
J Exp Med; 1980 Aug; 152(2 Pt 2):99s-113s. PubMed ID: 6967944
[TBL] [Abstract][Full Text] [Related]
9. [Autologous mixed lymphocyte culture (AMLC)].
Volk HD; Grunow R
Allerg Immunol (Leipz); 1984; 30(2):60-73. PubMed ID: 6237558
[TBL] [Abstract][Full Text] [Related]
10. All human monocytes have the capability of expressing HLA-DQ and HLA-DP molecules upon stimulation with interferon-gamma.
Gonwa TA; Frost JP; Karr RW
J Immunol; 1986 Jul; 137(2):519-24. PubMed ID: 3088102
[TBL] [Abstract][Full Text] [Related]
11. [HLA-DR antigens: cellular expression and molecular structure].
Charron DJ
Ann Immunol (Paris); 1982; 133D(2):155-69. PubMed ID: 6187269
[TBL] [Abstract][Full Text] [Related]
12. Ia antigen on peripheral blood mononuclear leukocytes in man. II. Functional studies of HLA-DR-positive T cells activated in mixed lymphocyte reactions.
Engleman EG; Benike CJ; Charron DJ
J Exp Med; 1980 Aug; 152(2 Pt 2):114s-126s. PubMed ID: 6447741
[TBL] [Abstract][Full Text] [Related]
13. The accessory cell function of human alveolar macrophages in specific T cell proliferation.
Toews GB; Vial WC; Dunn MM; Guzzetta P; Nunez G; Stastny P; Lipscomb MF
J Immunol; 1984 Jan; 132(1):181-6. PubMed ID: 6228577
[TBL] [Abstract][Full Text] [Related]
14. Human alveolar macrophages: HLA-DR-positive macrophages that are poor stimulators of a primary mixed leukocyte reaction.
Lipscomb MF; Lyons CR; Nunez G; Ball EJ; Stastny P; Vial W; Lem V; Weissler J; Miller LM
J Immunol; 1986 Jan; 136(2):497-504. PubMed ID: 2934472
[TBL] [Abstract][Full Text] [Related]
15. Mouse T lymphocytes proliferative responses specific for human MHC products in mouse anti-human xenogeneic MLR.
Yoshizawa K; Yano A
J Immunol; 1984 Jun; 132(6):2820-9. PubMed ID: 6202762
[TBL] [Abstract][Full Text] [Related]
16. Differential Ia antigen expression by autologous human erythroid and B lymphoblastoid cell lines.
Symington FW; Levine F; Braun M; Brown SL; Erlich HA; Torok-Storb B
J Immunol; 1985 Aug; 135(2):1026-32. PubMed ID: 3874223
[TBL] [Abstract][Full Text] [Related]
17. Cloned human cytotoxic T lymphocyte (CTL) lines reactive with autologous melanoma cells. I. In vitro generation, isolation, and analysis to phenotype and specificity.
de Vries JE; Spits H
J Immunol; 1984 Jan; 132(1):510-9. PubMed ID: 6197458
[TBL] [Abstract][Full Text] [Related]
18. Differential expression of HLA class II antigens in fetal human spleen: relationship of HLA-DP, DQ, and DR to immunoglobulin expression.
Edwards JA; Durant BM; Jones DB; Evans PR; Smith JL
J Immunol; 1986 Jul; 137(2):490-7. PubMed ID: 3522732
[TBL] [Abstract][Full Text] [Related]
19. High precursor frequency of human T cells reactive to HLA-DQ molecules expressed on mouse L cell transfectants.
Fujisawa K; Kamikawaji N; Yasunami M; Kimura A; Nishimura Y; Sasazuki T
Eur J Immunol; 1991 Oct; 21(10):2341-7. PubMed ID: 1717282
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of autologous mixed lymphocyte reaction by monoclonal antibodies specific for the beta chain of HLA-DR antigens.
Kasahara M; Ikeda H; Ogasawara K; Ishikawa N; Okuyama T; Fukasawa Y; Kojima H; Kunikane H; Hawkin S; Ohhashi T
Immunology; 1984 Sep; 53(1):79-86. PubMed ID: 6205985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
